Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	CHL1 PRTG PCDHGB2 PCDHGA10 PCDHGA5 PCDHGA1 CEACAM7 PTPRG	6.84e-06	187	109	8	GO:0007156
GeneOntologyCellularComponent	ciliary rootlet	KLC2 KLC3 KLC1	7.15e-05	16	108	3	GO:0035253
Domain	Kinesin_light	KLC2 KLC3 KLC1	7.08e-07	4	106	3	IPR002151
Domain	Rab5-bind	KLC2 KLC3 KLC1	3.51e-06	6	106	3	PF09311
Domain	Rabaptin_Rab5-bd_dom	KLC2 KLC3 KLC1	3.51e-06	6	106	3	IPR015390
Domain	FN3	CHL1 PRTG FN1 OBSCN PTPRG PTPRK ATF7IP2 IL5RA	1.78e-05	199	106	8	PS50853
Domain	FN3_dom	CHL1 PRTG FN1 OBSCN PTPRG PTPRK ATF7IP2 IL5RA	2.54e-05	209	106	8	IPR003961
Domain	Pumilio_RNA-bd	PUM2 PUM1	3.19e-05	2	106	2	IPR033712
Domain	RhoGEF	TRIO RASGRF2 OBSCN ITSN2 SOS1	4.20e-05	68	106	5	SM00325
Domain	RhoGEF	TRIO RASGRF2 OBSCN ITSN2 SOS1	4.83e-05	70	106	5	PF00621
Domain	DH_2	TRIO RASGRF2 OBSCN ITSN2 SOS1	4.83e-05	70	106	5	PS50010
Domain	-	TRIO RASGRF2 OBSCN ITSN2 SOS1	5.18e-05	71	106	5	1.20.900.10
Domain	DH-domain	TRIO RASGRF2 OBSCN ITSN2 SOS1	5.18e-05	71	106	5	IPR000219
Domain	Cadherin_tail	PCDHGB2 PCDHGA10 PCDHGA5 PCDHGA1	5.60e-05	37	106	4	PF15974
Domain	Cadherin_CBD	PCDHGB2 PCDHGA10 PCDHGA5 PCDHGA1	5.60e-05	37	106	4	IPR031904
Domain	Cadherin_C	PCDHGB2 PCDHGA10 PCDHGA5 PCDHGA1	9.29e-05	42	106	4	IPR032455
Domain	Cadherin_C_2	PCDHGB2 PCDHGA10 PCDHGA5 PCDHGA1	9.29e-05	42	106	4	PF16492
Domain	PUF	PUM2 PUM1	9.54e-05	3	106	2	PF00806
Domain	PUM_HD	PUM2 PUM1	9.54e-05	3	106	2	PS50303
Domain	KINESIN_LIGHT	KLC2 KLC1	9.54e-05	3	106	2	PS01160
Domain	PUM-HD	PUM2 PUM1	9.54e-05	3	106	2	IPR033133
Domain	Kinesin_light_repeat	KLC2 KLC1	9.54e-05	3	106	2	IPR015792
Domain	Ig_I-set	CHL1 PRTG TRIO CEACAM7 OBSCN PTPRK FGFR1	1.05e-04	190	106	7	IPR013098
Domain	I-set	CHL1 PRTG TRIO CEACAM7 OBSCN PTPRK FGFR1	1.05e-04	190	106	7	PF07679
Domain	PUM	PUM2 PUM1	1.90e-04	4	106	2	PS50302
Domain	Pumilio_RNA-bd_rpt	PUM2 PUM1	1.90e-04	4	106	2	IPR001313
Domain	Pumilio	PUM2 PUM1	1.90e-04	4	106	2	SM00025
Domain	fn3	CHL1 PRTG FN1 OBSCN PTPRG PTPRK	3.24e-04	162	106	6	PF00041
Domain	-	CHL1 PRTG FN1 TRIO CEACAM7 OBSCN MST1R CD1C PTPRG PTPRK FGFR1 IL5RA	3.79e-04	663	106	12	2.60.40.10
Domain	DH_1	TRIO RASGRF2 OBSCN SOS1	4.51e-04	63	106	4	PS00741
Domain	TPR_10	KLC2 KLC1	4.72e-04	6	106	2	PF13374
Domain	Cadherin_2	PCDHGB2 PCDHGA10 PCDHGA5 PCDHGA1	5.09e-04	65	106	4	PF08266
Domain	Cadherin_N	PCDHGB2 PCDHGA10 PCDHGA5 PCDHGA1	5.09e-04	65	106	4	IPR013164
Domain	FN3	CHL1 PRTG FN1 OBSCN PTPRG PTPRK	6.55e-04	185	106	6	SM00060
Domain	Galactosyl_T	B4GALT4 B4GALT3	6.58e-04	7	106	2	IPR003859
Domain	Glyco_transf_7N	B4GALT4 B4GALT3	6.58e-04	7	106	2	PF13733
Domain	Glyco_transf_7C	B4GALT4 B4GALT3	6.58e-04	7	106	2	PF02709
Domain	Galactosyl_T_C	B4GALT4 B4GALT3	6.58e-04	7	106	2	IPR027791
Domain	Galactosyl_T_N	B4GALT4 B4GALT3	6.58e-04	7	106	2	IPR027995
Domain	Ig-like_fold	CHL1 PRTG FN1 TRIO CEACAM7 OBSCN MST1R CD1C PTPRG PTPRK FGFR1 IL5RA	6.62e-04	706	106	12	IPR013783
Domain	TPR	CNOT10 KLC2 MAU2 KLC3 KLC1	8.44e-04	129	106	5	SM00028
Domain	DHC_N1	DYNC2H1 DNAH8	8.74e-04	8	106	2	PF08385
Domain	Dynein_heavy_dom-1	DYNC2H1 DNAH8	8.74e-04	8	106	2	IPR013594
Domain	TPR_repeat	CNOT10 KLC2 MAU2 KLC3 KLC1	9.68e-04	133	106	5	IPR019734
Domain	SAM_MT_PRMT	CARM1 PRMT8	1.12e-03	9	106	2	PS51678
Domain	Arg_MeTrfase	CARM1 PRMT8	1.12e-03	9	106	2	IPR025799
Domain	GDS_CDC24_CS	TRIO OBSCN SOS1	1.40e-03	39	106	3	IPR001331
Domain	TPR_1	CNOT10 KLC2 KLC3 KLC1	1.72e-03	90	106	4	IPR001440
Domain	TPR_1	CNOT10 KLC2 KLC3 KLC1	1.72e-03	90	106	4	PF00515
Domain	Dynein_heavy_chain_D4_dom	DYNC2H1 DNAH8	2.78e-03	14	106	2	IPR024317
Domain	Dynein_HC_stalk	DYNC2H1 DNAH8	2.78e-03	14	106	2	IPR024743
Domain	Dynein_heavy_dom-2	DYNC2H1 DNAH8	2.78e-03	14	106	2	IPR013602
Domain	DHC_N2	DYNC2H1 DNAH8	2.78e-03	14	106	2	PF08393
Domain	ATPase_dyneun-rel_AAA	DYNC2H1 DNAH8	2.78e-03	14	106	2	IPR011704
Domain	Ras_G-nucl-exch_fac_CS	RASGRF2 SOS1	2.78e-03	14	106	2	IPR019804
Domain	MT	DYNC2H1 DNAH8	2.78e-03	14	106	2	PF12777
Domain	AAA_8	DYNC2H1 DNAH8	2.78e-03	14	106	2	PF12780
Domain	AAA_5	DYNC2H1 DNAH8	2.78e-03	14	106	2	PF07728
Domain	DHC_fam	DYNC2H1 DNAH8	3.19e-03	15	106	2	IPR026983
Domain	Dynein_heavy	DYNC2H1 DNAH8	3.19e-03	15	106	2	PF03028
Domain	Dynein_heavy_dom	DYNC2H1 DNAH8	3.19e-03	15	106	2	IPR004273
Domain	Cadherin_CS	PCDHGB2 PCDHGA10 PCDHGA5 PCDHGA1	3.45e-03	109	106	4	IPR020894
Domain	CADHERIN_1	PCDHGB2 PCDHGA10 PCDHGA5 PCDHGA1	3.93e-03	113	106	4	PS00232
Domain	Cadherin	PCDHGB2 PCDHGA10 PCDHGA5 PCDHGA1	3.93e-03	113	106	4	PF00028
Domain	CADHERIN_2	PCDHGB2 PCDHGA10 PCDHGA5 PCDHGA1	4.06e-03	114	106	4	PS50268
Domain	-	PCDHGB2 PCDHGA10 PCDHGA5 PCDHGA1	4.06e-03	114	106	4	2.60.40.60
Domain	CA	PCDHGB2 PCDHGA10 PCDHGA5 PCDHGA1	4.18e-03	115	106	4	SM00112
Domain	Cadherin-like	PCDHGB2 PCDHGA10 PCDHGA5 PCDHGA1	4.31e-03	116	106	4	IPR015919
Domain	Cadherin	PCDHGB2 PCDHGA10 PCDHGA5 PCDHGA1	4.58e-03	118	106	4	IPR002126
Domain	RasGEFN	RASGRF2 SOS1	5.67e-03	20	106	2	SM00229
Pathway	KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT	TUBB8 KLC2 KLC3 KLC1	1.43e-05	24	89	4	M47671
Pathway	KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT	TUBB8 KLC2 KLC3 KLC1	1.70e-05	25	89	4	M47775
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT	TUBB8 KLC2 KLC3 KLC1	1.70e-05	25	89	4	M47710
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_ANTEROGRADE_AXONAL_TRANSPORT	KLC2 KLC3 KLC1	1.99e-05	9	89	3	M47699
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT	TUBB8 KLC2 KLC3 KLC1	2.00e-05	26	89	4	M47672
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_KTN1	KLC2 KLC3 KLC1	3.87e-05	11	89	3	M27490
Pathway	REACTOME_RHO_GTPASES_ACTIVATE_KTN1	KLC2 KLC3 KLC1	3.87e-05	11	89	3	MM15218
Pathway	KEGG_MEDICUS_VARIANT_OLIGOMERIC_CONFORMATION_PRPC_TO_ANTEROGRADE_AXONAL_TRANSPORT	KLC2 KLC3 KLC1	6.65e-05	13	89	3	M47763
Pathway	KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT	TUBB8 KLC2 KLC3 KLC1	6.69e-05	35	89	4	M47774
Pathway	REACTOME_MEMBRANE_TRAFFICKING	PACSIN1 TUBB8 CAPZA1 KLC2 COG3 COG6 LNPEP ITSN2 EXOC7 PUM1 GOLGA2 KLC3 KLC1	1.54e-04	630	89	13	M11480
Pathway	REACTOME_VESICLE_MEDIATED_TRANSPORT	PACSIN1 TUBB8 CAPZA1 KLC2 COG3 STAB1 COG6 LNPEP ITSN2 EXOC7 PUM1 GOLGA2 KLC3 KLC1	1.69e-04	725	89	14	M27507
Pathway	REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION	TUBB8 CAPZA1 COG3 COG6 GOLGA2 B4GALT4 B4GALT3	1.78e-04	187	89	7	M961
Pathway	REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC	TUBB8 CAPZA1 KLC2 COG3 COG6 KLC3 KLC1	2.94e-04	203	89	7	M27654
Pathway	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK	TRIO RASGRF2 OBSCN SOS1	3.19e-04	52	89	4	MM14743
Pathway	PID_TGFBR_PATHWAY	NEDD4L ZFYVE16 CAMK2A SOS1	3.69e-04	54	89	4	M286
Pathway	REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT	TUBB8 CAPZA1 COG3 COG6 GOLGA2	4.61e-04	102	89	5	M27648
Pathway	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK	TRIO RASGRF2 OBSCN SOS1	5.18e-04	59	89	4	M11215
Pathway	REACTOME_KINESINS	TUBB8 KLC2 KLC3 KLC1	5.89e-04	61	89	4	M977
Pubmed	Cayman ataxia protein caytaxin is transported by kinesin along neurites through binding to kinesin light chains.	KLC2 KLC3 KLC1	1.20e-07	4	109	3	19861499
Pubmed	Nesprin 4 is an outer nuclear membrane protein that can induce kinesin-mediated cell polarization.	KLC2 KLC3 KLC1	2.98e-07	5	109	3	19164528
Pubmed	Defective kinesin heavy chain behavior in mouse kinesin light chain mutants.	KLC2 KLC3 KLC1	2.98e-07	5	109	3	10491391
Pubmed	Two kinesin light chain genes in mice. Identification and characterization of the encoded proteins.	KLC2 KLC3 KLC1	2.48e-06	9	109	3	9624122
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ATP6V1B2 SETMAR FN1 TRIO CAMK2A HMOX2 STAB1 PPP4R3B ACAD8 PTPRK NAV3 DHX35 EXOC7 SOS1 BRWD1 B4GALT3	2.59e-06	1285	109	16	35914814
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	KRT5 ACACA TRIO TUBB8 CAPZA1 KLC2 PHKB ITSN2 NUP93 CGNL1 RMC1 KLC1 BRWD1	2.84e-06	853	109	13	28718761
Pubmed	TAp63 prevents premature aging by promoting adult stem cell maintenance.	KRT5 FN1 TP63	3.54e-06	10	109	3	19570515
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	KRT5 ACACA TRIO BMS1 PHKB TMPO AP3D1	3.63e-06	202	109	7	33005030
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	ACACA FN1 RASGRF2 OBSCN KLC2 NEB TMPO PUM1 AP3D1 GOLGA2	3.91e-06	497	109	10	36774506
Pubmed	The ciliary rootlet interacts with kinesin light chains and may provide a scaffold for kinesin-1 vesicular cargos.	KLC2 KLC3 KLC1	6.45e-06	12	109	3	16018997
Pubmed	Coordinated transport of phosphorylated amyloid-beta precursor protein and c-Jun NH2-terminal kinase-interacting protein-1.	KLC2 KLC3 KLC1	6.45e-06	12	109	3	16301330
Pubmed	Beta-1,4-galactosyltransferase-3 deficiency suppresses the growth of immunogenic tumors in mice.	B4GALT4 B4GALT3	9.73e-06	2	109	2	37901252
Pubmed	Cloning and comparative sequence analysis of PUM1 and PUM2 genes, human members of the Pumilio family of RNA-binding proteins.	PUM2 PUM1	9.73e-06	2	109	2	12459267
Pubmed	Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins.	PUM2 PUM1	9.73e-06	2	109	2	29165587
Pubmed	Stabilin-1 mediates beneficial monocyte recruitment and tolerogenic macrophage programming during CVB3-induced viral myocarditis.	FN1 STAB1	9.73e-06	2	109	2	34968453
Pubmed	PUMILIO-mediated translational control of somatic cell cycle program promotes folliculogenesis and contributes to ovarian cancer progression.	PUM2 PUM1	9.73e-06	2	109	2	35507203
Pubmed	Bespoke RNA recognition by Pumilios.	PUM2 PUM1	9.73e-06	2	109	2	26517885
Pubmed	Mouse Pum1 and Pum2 genes, members of the Pumilio family of RNA-binding proteins, show differential expression in fetal and adult hematopoietic stem cells and progenitors.	PUM2 PUM1	9.73e-06	2	109	2	12667987
Pubmed	Well-differentiated neuroendocrine tumors in skin: Terminology and diagnostic utility of cytokeratin 5/6 and p63.	KRT5 TP63	9.73e-06	2	109	2	28417484
Pubmed	A Quantitative and Predictive Model for RNA Binding by Human Pumilio Proteins.	PUM2 PUM1	9.73e-06	2	109	2	31078383
Pubmed	Principles of mRNA control by human PUM proteins elucidated from multimodal experiments and integrative data analysis.	PUM2 PUM1	9.73e-06	2	109	2	32753408
Pubmed	Crystal structures of the tetratricopeptide repeat domains of kinesin light chains: insight into cargo recognition mechanisms.	KLC2 KLC1	9.73e-06	2	109	2	22470497
Pubmed	Effects of PUMILIO1 and PUMILIO2 knockdown on cardiomyogenic differentiation of human embryonic stem cells culture.	PUM2 PUM1	9.73e-06	2	109	2	32437472
Pubmed	NEDD4L facilitates granulosa cell ferroptosis by promoting GPX4 ubiquitination and degradation.	NEDD4L GPX4	9.73e-06	2	109	2	36662677
Pubmed	Loss of p63 and cytokeratin 5/6 expression is associated with more aggressive tumors in endometrial carcinoma patients.	KRT5 TP63	9.73e-06	2	109	2	16152605
Pubmed	Characterization of RNP Networks of PUM1 and PUM2 Post-Transcriptional Regulators in TCam-2 Cells, a Human Male Germ Cell Model.	PUM2 PUM1	9.73e-06	2	109	2	32316190
Pubmed	Conserved mechanisms of microtubule-stimulated ADP release, ATP binding, and force generation in transport kinesins.	KLC3 KLC1	9.73e-06	2	109	2	25209998
Pubmed	Drug-induced lactate confers ferroptosis resistance via p38-SGK1-NEDD4L-dependent upregulation of GPX4 in NSCLC cells.	NEDD4L GPX4	9.73e-06	2	109	2	37188685
Pubmed	Structural plasticity of the N-terminal capping helix of the TPR domain of kinesin light chain.	KLC2 KLC1	9.73e-06	2	109	2	29036226
Pubmed	Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour.	FN1 FGFR1	9.73e-06	2	109	2	25319834
Pubmed	Adenosquamous carcinoma: a report of nine cases with p63 and cytokeratin 5/6 staining.	KRT5 TP63	9.73e-06	2	109	2	19278431
Pubmed	Rotavirus enterotoxin NSP4 binds to the extracellular matrix proteins laminin-beta3 and fibronectin.	FN1 LAMB3	9.73e-06	2	109	2	15331737
Pubmed	Genome-wide comparison of human keratinocyte and squamous cell carcinoma responses to UVB irradiation: implications for skin and epithelial cancer.	PUM2 PUM1	9.73e-06	2	109	2	12771951
Pubmed	Alternate modes of cognate RNA recognition by human PUMILIO proteins.	PUM2 PUM1	9.73e-06	2	109	2	21397187
Pubmed	Protein kinase A stimulates Kv7.1 surface expression by regulating Nedd4-2-dependent endocytic trafficking.	NEDD4L KCNQ1	9.73e-06	2	109	2	26405101
Pubmed	p63+Krt5+ basal cells are increased in the squamous metaplastic epithelium of patients with radiation-induced chronic Rhinosinusitis.	KRT5 TP63	9.73e-06	2	109	2	32977822
Pubmed	PUMILIO proteins promote colorectal cancer growth via suppressing p21.	PUM2 PUM1	9.73e-06	2	109	2	35338151
Pubmed	Comparative analysis of mRNA targets for human PUF-family proteins suggests extensive interaction with the miRNA regulatory system.	PUM2 PUM1	9.73e-06	2	109	2	18776931
Pubmed	Protein Tyrosine Phosphatase Receptor Type G (PTPRG) Controls Fibroblast Growth Factor Receptor (FGFR) 1 Activity and Influences Sensitivity to FGFR Kinase Inhibitors.	PTPRG FGFR1	9.73e-06	2	109	2	29371290
Pubmed	The Ras/Rac guanine nucleotide exchange factor mammalian Son-of-sevenless interacts with PACSIN 1/syndapin I, a regulator of endocytosis and the actin cytoskeleton.	PACSIN1 SOS1	9.73e-06	2	109	2	11352907
Pubmed	Regulation of kinesin light chain 1 level correlates with the development of morphine reward in the mouse brain.	CAMK2A KLC1	9.73e-06	2	109	2	19735294
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	KRT5 ATP6V1B2 CTTNBP2 NEDD4L FN1 TRIO PACSIN1 CAMK2A CAPZA1 KLC2 PHKB ITSN2 TMPO CGNL1 AP3D1 KLC1	1.00e-05	1431	109	16	37142655
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	EPPK1 ACACA RASGRF2 CAMK2A CNOT10 PARP3 CAPZA1 BAK1 KLC2 AZIN1 PPP4R3B RADIL NUP93 KLC3 KLC1	1.17e-05	1284	109	15	17353931
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	CHL1 PRTG TRIO CEACAM7 OBSCN PTPRK	1.27e-05	162	109	6	25826454
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	KRT5 DYNC2H1 CAPZA1 RNF8 BAK1 KLC2 POLR3C PPP4R3B CGNL1 GOLGA2	1.68e-05	588	109	10	38580884
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	CARM1 EPPK1 NEDD4L TRIO DYNC2H1 CNOT10 FGFR1 AP3D1	1.79e-05	358	109	8	32460013
Pubmed	A human MAP kinase interactome.	KRT5 NEDD4L PACSIN1 NEB ITSN2 NAV3 CGNL1 GOLGA2 SOS1	2.34e-05	486	109	9	20936779
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	KRT5 ATP6V1B2 TRIO ZFYVE16 BMS1 PPP4R3B PHKB PTPRG PTPRK LNPEP TMPO NUP93 PUM1	2.56e-05	1049	109	13	27880917
Pubmed	Stress-induced recruitment of epiplakin to keratin networks increases their resistance to hyperphosphorylation-induced disruption.	KRT5 EPPK1	2.91e-05	3	109	2	18285451
Pubmed	Antagonistic and cooperative AGO2-PUM interactions in regulating mRNAs.	PUM2 PUM1	2.91e-05	3	109	2	30333515
Pubmed	Novel recruitment of Shc, Grb2, and Sos by fibroblast growth factor receptor-1 in v-Src-transformed cells.	FGFR1 SOS1	2.91e-05	3	109	2	9480847
Pubmed	Spatially correlated phenotyping reveals K5-positive luminal progenitor cells and p63-K5/14-positive stem cell-like cells in human breast epithelium.	KRT5 TP63	2.91e-05	3	109	2	29743728
Pubmed	A novel function of human Pumilio proteins in cytoplasmic sensing of viral infection.	PUM2 PUM1	2.91e-05	3	109	2	25340845
Pubmed	Association of kinesin light chain with outer dense fibers in a microtubule-independent fashion.	KLC3 KLC1	2.91e-05	3	109	2	12594206
Pubmed	Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins.	PUM2 PUM1	2.91e-05	3	109	2	26724866
Pubmed	Genetic variation in glutathione S-transferase omega-1, arsenic methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: a case-control study.	AS3MT MTHFR	2.91e-05	3	109	2	22747749
Pubmed	Sequence analysis of the ERCC2 gene regions in human, mouse, and hamster reveals three linked genes.	KLC2 KLC3	2.91e-05	3	109	2	8786141
Pubmed	Oestrogen promotes KCNQ1 potassium channel endocytosis and postendocytic trafficking in colonic epithelium.	NEDD4L KCNQ1	2.91e-05	3	109	2	23529131
Pubmed	The Antigenic Determinant That Defines Thymic Nurse Cells Is Expressed by Thymic Epithelial Progenitor Cells.	KRT5 TP63	2.91e-05	3	109	2	25340052
Pubmed	Metabolism of low-dose inorganic arsenic in a central European population: influence of sex and genetic polymorphisms.	AS3MT MTHFR	2.91e-05	3	109	2	17637926
Pubmed	The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis.	MAGEA3 FN1	2.91e-05	3	109	2	18829569
Pubmed	Comparison of immunohistochemical staining in breast papillary neoplasms of cytokeratin 5/6 and p63 in core needle biopsies and surgical excisions.	KRT5 TP63	2.91e-05	3	109	2	22553810
Pubmed	Human Pumilio proteins directly bind the CCR4-NOT deadenylase complex to regulate the transcriptome.	PUM2 PUM1	2.91e-05	3	109	2	33397688
Pubmed	NORAD: Defender of the Genome.	PUM2 PUM1	2.91e-05	3	109	2	27157388
Pubmed	A phosphoinositide 3-kinase (PI3K)-serum- and glucocorticoid-inducible kinase 1 (SGK1) pathway promotes Kv7.1 channel surface expression by inhibiting Nedd4-2 protein.	NEDD4L KCNQ1	2.91e-05	3	109	2	24214981
Pubmed	PUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells.	PUM2 PUM1	2.91e-05	3	109	2	28232582
Pubmed	Cytokeratin 5/6 and P63 immunophenotype of thyroid lymphoepithelial complexes.	KRT5 TP63	2.91e-05	3	109	2	27130144
Pubmed	p63 protein is essential for the embryonic development of vibrissae and teeth.	KRT5 TP63	2.91e-05	3	109	2	16410075
Pubmed	COP9 signalosome component CSN-5 stabilizes PUF proteins FBF-1 and FBF-2 in Caenorhabditis elegans germline stem and progenitor cells.	PUM2 PUM1	2.91e-05	3	109	2	38427913
Pubmed	Galactosylation of N-linked oligosaccharides by human beta-1,4-galactosyltransferases I, II, III, IV, V, and VI expressed in Sf-9 cells.	B4GALT4 B4GALT3	2.91e-05	3	109	2	11588157
Pubmed	Decreased expression of FGFR1, SOS1, RAF1 genes in cryptorchidism.	FGFR1 SOS1	2.91e-05	3	109	2	20389169
Pubmed	MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes.	NEDD4L KCNQ1	2.91e-05	3	109	2	32173736
Pubmed	The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.	KRT5 TP63	2.91e-05	3	109	2	25944390
Pubmed	Pumilio facilitates miRNA regulation of the E2F3 oncogene.	PUM2 PUM1	2.91e-05	3	109	2	22345517
Pubmed	A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.	EPPK1 ACACA LAMB3 HMOX2 COG3 TMPO NUP93 AP3D1 GOLGA2	3.06e-05	503	109	9	36217030
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	EPPK1 ACACA TRIO OBSCN LAMB3 MST1R RADIL MTHFR USP40 FGFR1 PUM1 ZNF614 AP3D1	4.37e-05	1105	109	13	35748872
Pubmed	E3 ubiquitin ligase RFWD2 controls lung branching through protein-level regulation of ETV transcription factors.	KRT5 NEDD4L TP63	4.42e-05	22	109	3	27335464
Pubmed	BIM regulates apoptosis during mammary ductal morphogenesis, and its absence reveals alternative cell death mechanisms.	KRT5 FN1 TP63	4.42e-05	22	109	3	17276340
Pubmed	Localized Fgf10 expression is not required for lung branching morphogenesis but prevents differentiation of epithelial progenitors.	KRT5 FN1 TP63	5.07e-05	23	109	3	23924632
Pubmed	Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.	KRT5 TP63	5.82e-05	4	109	2	21164283
Pubmed	Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.	KRT5 TP63	5.82e-05	4	109	2	26447895
Pubmed	Distinct expression profiles of p63 variants during urothelial development and bladder cancer progression.	KRT5 TP63	5.82e-05	4	109	2	21356385
Pubmed	Exome sequencing in seven families and gene-based association studies indicate genetic heterogeneity and suggest possible candidates for fibromuscular dysplasia.	DYNC2H1 OBSCN	5.82e-05	4	109	2	26147384
Pubmed	Deubiquitylating enzyme USP2 counteracts Nedd4-2-mediated downregulation of KCNQ1 potassium channels.	NEDD4L KCNQ1	5.82e-05	4	109	2	22024150
Pubmed	ΔNp63 drives dysplastic alveolar remodeling and restricts epithelial plasticity upon severe lung injury.	KRT5 TP63	5.82e-05	4	109	2	36516758
Pubmed	Shc and a novel 89-kDa component couple to the Grb2-Sos complex in fibroblast growth factor-2-stimulated cells.	FGFR1 SOS1	5.82e-05	4	109	2	7559490
Pubmed	Mammalian Pum1 and Pum2 Control Body Size via Translational Regulation of the Cell Cycle Inhibitor Cdkn1b.	PUM2 PUM1	5.82e-05	4	109	2	30811992
Pubmed	Kinesin light-chain KLC3 expression in testis is restricted to spermatids.	KLC3 KLC1	5.82e-05	4	109	2	11319135
Pubmed	An active role of the DeltaN isoform of p63 in regulating basal keratin genes K5 and K14 and directing epidermal cell fate.	KRT5 TP63	5.82e-05	4	109	2	19461998
Pubmed	S100A1 expression characterizes terminally differentiated superficial cells in the urothelium of the murine bladder and ureter.	KRT5 TP63	5.82e-05	4	109	2	35648290
Pubmed	Kinesin-dependent axonal transport is mediated by the sunday driver (SYD) protein.	KLC2 KLC1	5.82e-05	4	109	2	11106729
Pubmed	Point mutation in the fibroblast growth factor receptor eliminates phosphatidylinositol hydrolysis without affecting neuronal differentiation of PC12 cells.	FGFR1 SOS1	5.82e-05	4	109	2	7514169
Pubmed	Interaction of nebulin SH3 domain with titin PEVK and myopalladin: implications for the signaling and assembly role of titin and nebulin.	NEB SOS1	5.82e-05	4	109	2	12482578
Pubmed	Kinase-dependent adhesion to fibronectin: regulation by calreticulin.	FN1 CAMK2A	5.82e-05	4	109	2	18255058
Pubmed	Utility of WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions.	KRT5 TP63	5.82e-05	4	109	2	18064689
Pubmed	Target RNA motif and target mRNAs of the Quaking STAR protein.	PUM2 PUM1	5.82e-05	4	109	2	16041388
Pubmed	Galphaq directly activates p63RhoGEF and Trio via a conserved extension of the Dbl homology-associated pleckstrin homology domain.	TRIO TP63	5.82e-05	4	109	2	17606614
Pubmed	The neural cell adhesion molecule promotes FGFR-dependent phosphorylation and membrane targeting of the exocyst complex to induce exocytosis in growth cones.	FGFR1 EXOC7	5.82e-05	4	109	2	21389209
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHGB2 PCDHGA10 PCDHGA5 PCDHGA1	6.37e-05	68	109	4	11230163
Pubmed	Mutation specific functions of EGFR result in a mutation-specific downstream pathway activation.	LAMB3 NUP93 EXOC7 SOS1	6.37e-05	68	109	4	25754235
Interaction	KIF5C interactions	MAGEA3 KLC2 AZIN1 COG6 FGFR1 KLC3 KLC1	4.08e-07	88	106	7	int:KIF5C
Interaction	KIF5B interactions	CARM1 ACACA CAPZA1 KLC2 AZIN1 PPP4R3B COG6 RMC1 EXOC7 KLC3 KLC1	2.24e-06	348	106	11	int:KIF5B
Interaction	KLC1 interactions	CARM1 ACACA CAPZA1 KLC2 AZIN1 PPP4R3B COG6 KLC3 KLC1	8.15e-06	255	106	9	int:KLC1
Interaction	FHIP2B interactions	DYNC2H1 KLC2 KLC3 KLC1	2.97e-05	34	106	4	int:FHIP2B
Interaction	KLC2 interactions	KLC2 AZIN1 PPP4R3B COG6 AP3D1 KLC3 KLC1	3.50e-05	172	106	7	int:KLC2
Cytoband	5q31	PCDHGB2 PCDHGA10 PCDHGA5 PCDHGA1	1.70e-04	115	109	4	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr3p26	CHL1 SETMAR IL5RA	2.22e-04	49	109	3	chr3p26
Cytoband	3p26.1	CHL1 SETMAR	3.63e-04	12	109	2	3p26.1
Cytoband	5p15.2	TRIO MARCHF6	1.89e-03	27	109	2	5p15.2
Cytoband	Ensembl 112 genes in cytogenetic band chr1q23	CD1C NR1I3 MPTX1 B4GALT3	2.12e-03	226	109	4	chr1q23
Cytoband	15q21.3	PRTG CGNL1	3.16e-03	35	109	2	15q21.3
GeneFamily	Fibronectin type III domain containing	CHL1 PRTG FN1 OBSCN PTPRG PTPRK ATF7IP2	5.33e-06	160	77	7	555
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	TRIO RASGRF2 OBSCN ITSN2 SOS1	8.96e-06	66	77	5	722
GeneFamily	Clustered protocadherins	PCDHGB2 PCDHGA10 PCDHGA5 PCDHGA1	1.59e-04	64	77	4	20
GeneFamily	Components of oligomeric golgi complex	COG3 COG6	4.93e-04	8	77	2	493
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	CHL1 PRTG TRIO OBSCN FGFR1	6.20e-04	161	77	5	593
GeneFamily	Protein arginine methyltransferases	CARM1 PRMT8	6.32e-04	9	77	2	691
GeneFamily	AF4/FMR2 family\|Super elongation complex	ELL3 AFF1	6.32e-04	9	77	2	1280
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	CNOT10 KLC2 KLC3 KLC1	1.47e-03	115	77	4	769
GeneFamily	Beta 4-glycosyltransferases	B4GALT4 B4GALT3	2.34e-03	17	77	2	425
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRG PTPRK	3.57e-03	21	77	2	813
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	MAGEA3 FN1 TRIO DYNC2H1 STK17B LAMB3 THOC2 POLR3C PPP4R3B LNPEP TMPO ZCCHC7 AP3D1 BRWD1	1.61e-06	721	108	14	M10237
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	CRADD TRIO ZFYVE16 MARCHF6 PUM2 THOC2 AZIN1 KIN PTPRK ITSN2 NAV3 AFF1 PUM1 KLC1 SOS1	2.35e-06	856	108	15	M4500
ToppCell	metastatic_Lymph_Node-T/NK_cells-CD8_low_T\|T/NK_cells / Location, Cell class and cell subclass	CHL1 PACSIN1 RTN2 PPP2R2B PTPRG NAV3 IL5RA	7.63e-08	148	108	7	db046a02a00829910bf9d7dbda068e730aa78f00
ToppCell	facs-Lung-nan-3m-Epithelial-type_I_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 CTTNBP2 RASGRF2 PCDHGA10 LAMB3 RADIL	3.23e-06	166	108	6	11b0ae82b3068ef91715dbdd49fe8e9791b4a480
ToppCell	facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 CTTNBP2 RASGRF2 PCDHGA10 LAMB3 RADIL	3.23e-06	166	108	6	fcc1aec31ebd39432d4cb284dc8fadf34e3c566a
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-Pleural_Mac\|Myeloid_cells / Location, Cell class and cell subclass	SETMAR OBSCN BAK1 MAU2 KIN GOLGA2	3.46e-06	168	108	6	8697b40b2ec2cce68ef3beb4792eb3eff29be053
ToppCell	droplet-Liver-Hepatocytes-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VASH1 RTN2 POLR3C KCNQ1 DHX35 GOLGA2	6.02e-06	185	108	6	60206c7322b4ddb2010040aac70561df842c9843
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PRTG NEDD4L ACACA PTPRG PTPRK CGNL1	7.23e-06	191	108	6	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D122\|Adult / Lineage, Cell type, age group and donor	PRTG NEDD4L ACACA ARMC9 PTPRG PTPRK	7.45e-06	192	108	6	06013a07e3a873b1d1c0451643c528593ac32a9c
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	ZFYVE16 THOC2 PTPRK AFF1 LRRC8B PUM1	7.67e-06	193	108	6	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	facs-Tongue\|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 KRT5 EPPK1 LAMB3 TP63 KLC3	8.14e-06	195	108	6	77128895db9221a64a171082d468ebcd6380c936
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	NEDD4L ACACA PTPRG PTPRK ZCCHC7 SOS1	8.38e-06	196	108	6	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KRT5 LAMB3 PPP2R2B TP63 NAV3 FGFR1	8.62e-06	197	108	6	f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e
ToppCell	facs-Tongue-nan-3m-Epithelial\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 EPPK1 CAPZA1 PPP4R3B TP63 AFF1	8.87e-06	198	108	6	2f03f8897dd7cce6d8296638e14e11ec16bcf624
ToppCell	facs-Tongue-nan-3m\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 EPPK1 CAPZA1 PPP4R3B TP63 AFF1	8.87e-06	198	108	6	f2a4057f038ef7225a5b98a7ab068c30dff4eadd
ToppCell	Tracheal-10x5prime-Epithelial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CHL1 KRT5 NEDD4L MUC16 LAMB3 TP63	9.40e-06	200	108	6	efd461c687155c84ef590352207e6fe4ba392a90
ToppCell	(08)_PNEC-(2)_48hpi\|(08)_PNEC / shred by cell type and Timepoint	CTTNBP2 ZFYVE16 ARMC9 NEB RMC1	2.50e-05	142	108	5	e95d34170f5053678e0dd9793e68d93c03b05822
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CTTNBP2 MUC16 ELL3 STAB1 PHKB	3.15e-05	149	108	5	a85a051e0d82430160967e72fa04b55f43e84513
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CTTNBP2 MUC16 ELL3 STAB1 PHKB	3.26e-05	150	108	5	7a381f5ae94eba5eb60dcbf83416b4eb18c279ea
ToppCell	Bac-SEP-Myeloid-tDC\|Bac-SEP / Disease, Lineage and Cell Type	TRIO VASH1 KLC2 RTN2 CD1C	5.13e-05	165	108	5	8728f927502e56f2768b4224e9111939d3d7815a
ToppCell	facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPPK1 CTTNBP2 RASGRF2 LAMB3 RADIL	5.43e-05	167	108	5	bebc2493a2ee41920b21c2b774a1c5a9619315c4
ToppCell	facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	EPPK1 CTTNBP2 RASGRF2 LAMB3 RADIL	5.43e-05	167	108	5	9f2661729a2d58e17a9203a563d538c08a3dbbbc
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231\|Adult / Lineage, Cell type, age group and donor	PRTG PRMT8 NEDD4L ACACA PTPRK	5.91e-05	170	108	5	269dee5abca9f6aa079f116f0d8f1d198604d9d4
ToppCell	Bronchial_Biopsy-Immune-Mast_cells\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	CTTNBP2 VASH1 STAB1 TPSD1 NR1I3	6.25e-05	172	108	5	c477008444d2d71071177807870d7455e90c2fad
ToppCell	Nasal_Brush-Epithelial-Basal_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	KRT5 FN1 TP63 FGFR1 CGNL1	6.25e-05	172	108	5	58eaadf12366701103a0d1f133462c9495fedc30
ToppCell	Nasal_Brush-Epithelial-Basal_1\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	KRT5 FN1 TP63 FGFR1 CGNL1	6.25e-05	172	108	5	4483073469001770015526303772fd54906c5d68
ToppCell	Adult-Epithelial-basal_cell-D231\|Adult / Lineage, Cell type, age group and donor	CHL1 KRT5 PRMT8 LAMB3 TP63	6.60e-05	174	108	5	a4f98afe7d1cc2617f6f7bc8092c41df57474b30
ToppCell	15-Trachea-Mesenchymal-Mesenchyme_RSPO2+\|Trachea / Age, Tissue, Lineage and Cell class	CARM1 FN1 MST1R TP63 FGFR1	6.60e-05	174	108	5	fa0681e91724b9a51ee28b214ea5aa14e62ba1a3
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_activate-7\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NEB CD1C PTPRK USP40 ZCCHC7	6.96e-05	176	108	5	dde46f06f6fc3f7ba83be91a0ee6231790955e3e
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SETMAR NEDD4L LAMB3 RADIL TP63	7.15e-05	177	108	5	75cb2067a3f2d1b5a964890b02b604d1e79bd163
ToppCell	COPD-Epithelial-Basal\|World / Disease state, Lineage and Cell class	KRT5 NEDD4L LAMB3 PTPRK TP63	7.95e-05	181	108	5	6d8a886b4afe729f8a05b9c0f4ea9375de735da4
ToppCell	Control-Epithelial-Basal\|World / Disease state, Lineage and Cell class	KRT5 NEDD4L LAMB3 PTPRK TP63	8.16e-05	182	108	5	759390dde9b18757f7675d13d44c89d0e32f8d93
ToppCell	Control-Epithelial-Basal\|Control / Disease state, Lineage and Cell class	KRT5 NEDD4L LAMB3 PTPRK TP63	8.16e-05	182	108	5	caddd0a52f0234ea6a916186ffaf2454cdcd80ee
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PRTG NEDD4L ACACA PTPRK CGNL1	8.37e-05	183	108	5	6847c1252d6bb105524f812658112517fd351eab
ToppCell	COPD-Epithelial-Basal\|COPD / Disease state, Lineage and Cell class	KRT5 NEDD4L LAMB3 PTPRK TP63	8.37e-05	183	108	5	0f760e393edc91009bf6c7e02eeac039a1dfb4ed
ToppCell	facs-Lung-EPCAM-3m-Epithelial-Basal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT5 EPPK1 LAMB3 TP63 KLC3	8.37e-05	183	108	5	ecac1cfaff7553a60305b34d6cede6973ffb5430
ToppCell	facs-Lung-EPCAM-3m-Epithelial-respiratory_basal_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT5 EPPK1 LAMB3 TP63 KLC3	8.37e-05	183	108	5	f6ebfd7f61e912f92bd07313cc213a171747ac03
ToppCell	droplet-Skin\|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 KRT5 EPPK1 TP63 KLC3	8.81e-05	185	108	5	657fd191ed160f8620d57b33820ec7222806f289
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-3\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT5 LAMB3 MST1R TP63 KLC3	9.04e-05	186	108	5	29c79b5a29907d4f3f87ad2ca04840c0f15b7d4e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CHL1 CTTNBP2 PTPRG LNPEP CGNL1	9.27e-05	187	108	5	c41a2c81dd2ceef303f39f699032aa7d6ea67cf0
ToppCell	COVID-19-Epithelial_cells-Airway_basal\|COVID-19 / group, cell type (main and fine annotations)	KRT5 NEDD4L LAMB3 PTPRK TP63	9.27e-05	187	108	5	8407a82e98f56a94ea26562bcb6bbe00a8f41661
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D175\|Adult / Lineage, Cell type, age group and donor	PRTG EPPK1 ACACA ARMC9 PTPRG	9.50e-05	188	108	5	ec38def1fdbb34ed9b30244806975bd5a4370164
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CHL1 LAMB3 MST1R PTPRG LNPEP	9.74e-05	189	108	5	aadb7a2de4cbe7f0958651f2739bba430b93f5c1
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CHL1 LAMB3 MST1R PTPRG LNPEP	9.74e-05	189	108	5	8977f3295b7df7c7474b3f371de90a82ae4bb50c
ToppCell	facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KRT5 EPPK1 LAMB3 PPP2R2B TP63	9.99e-05	190	108	5	47e07ea22733306d8885ee9e5f0b033e2f5e2afb
ToppCell	facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KRT5 EPPK1 LAMB3 PPP2R2B TP63	9.99e-05	190	108	5	261b8afddfdcba4f70b50df126cef7ad00a0aae0
ToppCell	IPF-Epithelial-Basal\|IPF / Disease state, Lineage and Cell class	KRT5 NEDD4L LAMB3 PTPRK TP63	9.99e-05	190	108	5	ea19e9ce954f2dfde97388db9695325cd92ab88f
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CHL1 PPP2R2B PTPRG LNPEP CGNL1	9.99e-05	190	108	5	59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a
ToppCell	facs-Skin\|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 KRT5 LAMB3 TP63 KLC3	1.02e-04	191	108	5	ae524103331fa53fa82888dbb567fc36abcee7e0
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CHL1 KRT5 MUC16 MST1R PTPRK	1.05e-04	192	108	5	8899d81306770adda893b5e146df1253971754c5
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	PRTG NEDD4L ACACA PTPRG PTPRK	1.05e-04	192	108	5	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CHL1 KRT5 MUC16 MST1R PTPRK	1.05e-04	192	108	5	5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a
ToppCell	IPF-Epithelial-Club\|Epithelial / Disease state, Lineage and Cell class	NEDD4L ACACA RTN2 PTPRG CGNL1	1.05e-04	192	108	5	356e7a820b744a0ac87352a8d0e6e8d9fa9ed7d2
ToppCell	IPF-Epithelial-Basal\|World / Disease state, Lineage and Cell class	KRT5 NEDD4L LAMB3 PTPRK TP63	1.05e-04	192	108	5	9b91e0b162e6f3ce86dd15cc33c2e745d069581f
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PRTG NEDD4L ACACA PTPRG PTPRK	1.07e-04	193	108	5	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2\|Adult / Lineage, Cell type, age group and donor	PRTG ACACA ARMC9 PTPRG PTPRK	1.07e-04	193	108	5	738f4f0a9ddde2432b429ab46838e353b1790589
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PRTG NEDD4L ACACA PTPRG PTPRK	1.07e-04	193	108	5	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NEDD4L ACACA PTPRK ATF7IP2 CGNL1	1.10e-04	194	108	5	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NEDD4L ACACA PTPRK ATF7IP2 CGNL1	1.13e-04	195	108	5	9406866f99555198a9be311fbd65751b70f35446
ToppCell	COVID-19-Epithelial-Club,_Basal_cells\|COVID-19 / Condition, Lineage and Cell class	CHL1 KRT5 MUC16 PTPRK TP63	1.16e-04	196	108	5	dd32046067d93b9484cfbf1d7826a436a3d9f0e9
ToppCell	facs-Skin-Telogen-3m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LAMB3 AZIN1 PTPRK FGFR1 CGNL1	1.16e-04	196	108	5	c936014125b2ed5f796221b74acb77b8f8359875
ToppCell	cellseq-Epithelial-Epithelial_Airway\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CHL1 KRT5 MUC16 LAMB3 TP63	1.16e-04	196	108	5	faa39c567f24403e511b240c1d1a654ffadd8473
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT5 EPPK1 LAMB3 PTPRK KLC3	1.18e-04	197	108	5	f4dad4423384a2a25e064c849ffccf2811573be0
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	KRT5 NEDD4L LAMB3 TP63 KLC3	1.18e-04	197	108	5	751f19b00f92e1334f653b870d3f7c0c149ff41a
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PRTG FN1 PTPRG NAV3 FGFR1	1.18e-04	197	108	5	2f72fd9a5b6d62c24a95ed2246194ea7458c0f12
ToppCell	Severe_COVID-19-Epithelial-transitional_Epi\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	CHL1 EPPK1 DYNC2H1 MUC16 LAMB3	1.18e-04	197	108	5	5ad3cd4c77016e862041baac3076f8cc0f75c417
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-Basal_1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	KRT5 NEDD4L LAMB3 TP63 KLC3	1.18e-04	197	108	5	2701864e49878c5f323f5133e2c4b0a5a7fff7f5
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KRT5 NEDD4L LAMB3 TP63 KLC3	1.18e-04	197	108	5	58d809ccb8cc4b1e76acf0b8f996cd0e2637290c
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FN1 PPP2R2B NAV3 FGFR1 CGNL1	1.21e-04	198	108	5	9541d68a1a6247dbd7161a62644eea6527c2c8ff
ToppCell	BAL-Severe-Epithelial-Epithelial-AT1/AT2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PRTG NEDD4L LAMB3 PTPRG CGNL1	1.21e-04	198	108	5	691a2f1779225e5519155460eeb6a2aac5f67a92
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_2-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CHL1 KRT5 MUC16 LAMB3 KLC3	1.21e-04	198	108	5	a54ae5275a510b49d7629f0908817a0c5f05020e
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRTG NEDD4L ACACA PTPRG PTPRK	1.21e-04	198	108	5	f948391296c261c473d339069a6d0f20ccd6f38f
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_2\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CHL1 KRT5 MUC16 LAMB3 KLC3	1.21e-04	198	108	5	34997e3896d0893fbe51bfb0d4660ccaca1c975e
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	NEDD4L ACACA TRIO PTPRG PTPRK	1.21e-04	198	108	5	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRTG NEDD4L ACACA PTPRG PTPRK	1.21e-04	198	108	5	2e2a4e1756bba6f4fbe529559a97d2993c890b4b
ToppCell	BAL-Severe-Epithelial-Epithelial-AT1/AT2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PRTG NEDD4L LAMB3 PTPRG CGNL1	1.21e-04	198	108	5	aed0476248e9637897eefb1623ec4035f2dacd82
ToppCell	BAL-Severe-Epithelial-Epithelial-AT1/AT2\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	PRTG NEDD4L LAMB3 PTPRG CGNL1	1.21e-04	198	108	5	e115eea04012e9e492e923ed080e1723c38d14fd
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-Basal_2\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	CHL1 KRT5 MUC16 LAMB3 KLC3	1.21e-04	198	108	5	686eda427b075e788de38149eae82faf19bd5704
ToppCell	BAL-Severe-Epithelial-Epithelial-AT1/AT2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PRTG NEDD4L LAMB3 PTPRG CGNL1	1.21e-04	198	108	5	33d1e0b6f57663544bee0ffdde83a65da764d44c
ToppCell	Severe_COVID-19-Epithelial-AT1/AT2\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	PRTG NEDD4L LAMB3 PTPRG CGNL1	1.21e-04	198	108	5	43e33d28d9de5033bd00d39be953542a225236ed
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CHL1 KRT5 OBSCN LAMB3 TP63	1.21e-04	198	108	5	5374b0e98d669f36a0571d3c006c7bd5e3c8e87f
ToppCell	BAL-Severe-Epithelial-Epithelial-Basal/Club\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CHL1 KRT5 MUC16 LAMB3 PTPRK	1.24e-04	199	108	5	d04062d86643e5712cc2f519f4f36e643d404a16
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CHL1 KRT5 OBSCN LAMB3 TP63	1.24e-04	199	108	5	94a7867e800df352731796de8c24cba133c29622
ToppCell	BAL-Severe-Epithelial-Epithelial-Basal/Club-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CHL1 KRT5 MUC16 LAMB3 PTPRK	1.24e-04	199	108	5	a3f83fe5c3c557cd3ef8f5632f7fba5cf1859937
ToppCell	Sepsis-Bac-SEP-Myeloid-tDC\|Bac-SEP / Disease, condition lineage and cell class	TRIO VASH1 KLC2 RTN2 CD1C	1.24e-04	199	108	5	a2be40d367338d32348a6906c8475aa3b544a0f7
ToppCell	BAL-Severe-Epithelial-Epithelial-Basal/Club\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	CHL1 KRT5 MUC16 LAMB3 PTPRK	1.24e-04	199	108	5	644197ff7e3299587881dd678836262e670ed4a8
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	ACACA TRIO AFF1 ZCCHC7 SOS1	1.24e-04	199	108	5	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Frontal_cortex-Neuronal\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	CHL1 ATP6V1B2 PACSIN1 KLC2 KLC1	1.24e-04	199	108	5	f88039d862f3bfa01dc39d2de4f3f548dc5a0e61
ToppCell	Severe_COVID-19-Epithelial-Basal/Club\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	CHL1 KRT5 MUC16 LAMB3 PTPRK	1.24e-04	199	108	5	2a0aebcfadff4e2dfc8244ad8a87c338ecccacfd
ToppCell	BAL-Severe-Epithelial-Epithelial-Basal/Club-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CHL1 KRT5 MUC16 LAMB3 PTPRK	1.24e-04	199	108	5	fd364f43859b2e7a3e91ce6a1c430cc42ad26a49
ToppCell	cellseq2-Epithelial-Epithelial_Glandular-MEC\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	KRT5 LAMB3 TP63 FGFR1 KLC3	1.27e-04	200	108	5	53160551d558148d1d80ec87b90dd6be7d36e4c7
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_3-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KRT5 EPPK1 LAMB3 TP63 KLC3	1.27e-04	200	108	5	41705bbba40eb5ddca0b223191aac1bce00163b8
ToppCell	cellseq2-Epithelial-Epithelial_Glandular-MEC-MEC\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	KRT5 LAMB3 TP63 FGFR1 KLC3	1.27e-04	200	108	5	af4d922659b6f9d446797f7a3922a211e22f88e4
ToppCell	TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	CARM1 TRIO KLC2 EXOC7 KLC3	1.27e-04	200	108	5	1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NEDD4L ACACA MUC16 PTPRK CGNL1	1.27e-04	200	108	5	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-BMP_responsible_cell\|6m / Sample Type, Dataset, Time_group, and Cell type.	PRTG ZFYVE16 AFF1 CGNL1 MAP3K19	1.27e-04	200	108	5	5fb90118d3abc28d72bc483e68317255090a04c7
ToppCell	Parenchyma_COVID-19-Epithelial-TX-Basal_3\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	KRT5 EPPK1 LAMB3 TP63 KLC3	1.27e-04	200	108	5	53e04399d0308b40ae99fbfaa4ff62bf061822d8
ToppCell	Control_saline-Endothelial-Endothelial-Artery\|Control_saline / Treatment groups by lineage, cell group, cell type	CTTNBP2 FN1 AZIN1 PTPRG ITSN2	1.27e-04	200	108	5	65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_basal-Basal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CHL1 KRT5 OBSCN LAMB3 TP63	1.27e-04	200	108	5	9da214f756a03516eaafde00289b90f69623b9f3
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_3\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	KRT5 EPPK1 LAMB3 TP63 KLC3	1.27e-04	200	108	5	cc8df398532c9324fd3e171000b1ea5c208cd691
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CHL1 KRT5 MUC16 PTPRK TP63	1.27e-04	200	108	5	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	distal-Epithelial-Basal-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	KRT5 NEDD4L LAMB3 TP63 KLC3	1.27e-04	200	108	5	6f00d08e93f89b3575ebbd5c2f451e655d449ef3
Disease	Alzheimer's disease 1 (implicated_via_orthology)	KLC2 KLC3 KLC1	1.43e-06	7	103	3	DOID:0080348 (implicated_via_orthology)
Disease	mental development measurement	PCDHGB2 PCDHGA10 PCDHGA5 PCDHGA1	1.67e-06	25	103	4	EFO_0008230
Disease	Gingival overgrowth	REST SOS1	1.21e-05	2	103	2	cv:C0376480
Disease	Hereditary gingival fibromatosis	REST SOS1	1.21e-05	2	103	2	cv:C0399440
Disease	Hereditary gingival fibromatosis	REST SOS1	3.61e-05	3	103	2	C0399440
Disease	Sarcosine measurement	PCDHGB2 PCDHGA5 PCDHGA1	6.95e-05	23	103	3	EFO_0021668
Disease	childhood trauma measurement, alcohol consumption measurement	PCDHGB2 PCDHGA10 PCDHGA5 PCDHGA1	1.14e-04	71	103	4	EFO_0007878, EFO_0007979
Disease	Colorectal Carcinoma	CHL1 ACACA FN1 RASGRF2 GPX4 OBSCN LAMB3 MTHFR TP63 DNAH8	1.76e-04	702	103	10	C0009402
Disease	smoking status measurement	CTTNBP2 RASGRF2 STK17B AS3MT REST STAB1 PTPRG PTPRK LNPEP FGFR1 RMC1 DNAH8 BRWD1	2.02e-04	1160	103	13	EFO_0006527
Disease	myeloid neoplasm (is_implicated_in)	MTHFR FGFR1	2.51e-04	7	103	2	DOID:0070004 (is_implicated_in)
Disease	Spondylometaphyseal dysplasia	FN1 GPX4	2.51e-04	7	103	2	cv:C4759767
Disease	Type II Collagenopathies	FN1 GPX4	2.51e-04	7	103	2	cv:CN043672
Disease	Cleft upper lip	MTHFR TP63 FGFR1	3.45e-04	39	103	3	C0008924
Disease	Malignant neoplasm of breast	KRT5 FN1 RASGRF2 DYNC2H1 GPX4 OBSCN COG3 PHKB MTHFR ITSN2 AFF1 FGFR1	3.70e-04	1074	103	12	C0006142
Disease	corpus callosum volume measurement	CTTNBP2 MST1R NAV3 SOS1	4.25e-04	100	103	4	EFO_0010299
Disease	Cleft palate, isolated	NEDD4L TP63 FGFR1	4.30e-04	42	103	3	C1837218
Disease	liver cirrhosis (is_implicated_in)	VASH1 AZIN1 MTHFR	4.61e-04	43	103	3	DOID:5082 (is_implicated_in)
Disease	mean reticulocyte volume	STK17B PCDHGA5 AS3MT MAU2 REST NEB AZIN1 KIN MTHFR AFF1	4.90e-04	799	103	10	EFO_0010701
Disease	Cryptorchidism	GPX4 PUM1	5.33e-04	10	103	2	C0010417
Disease	Hypertrophic Cardiomyopathy	OBSCN TMPO KCNQ1	1.05e-03	57	103	3	C0007194
Disease	nephroblastoma (is_implicated_in)	REST MTHFR	1.07e-03	14	103	2	DOID:2154 (is_implicated_in)
Disease	atrial fibrillation (is_implicated_in)	AGXT2 KCNQ1	1.07e-03	14	103	2	DOID:0060224 (is_implicated_in)
Disease	renal cell carcinoma (is_marker_for)	FN1 BAK1 LNPEP FGFR1	1.07e-03	128	103	4	DOID:4450 (is_marker_for)
Disease	cognitive behavioural therapy	CRADD NEB FGFR1	1.11e-03	58	103	3	EFO_0007820
Disease	cleft lip (is_implicated_in)	MTHFR FGFR1	1.23e-03	15	103	2	DOID:9296 (is_implicated_in)
Disease	Lymphoma, Follicular, Grade 2	ATP6V1B2 MTHFR	1.23e-03	15	103	2	C1956132
Disease	Lymphoma, Follicular, Grade 3	ATP6V1B2 MTHFR	1.23e-03	15	103	2	C1956131
Disease	Lymphoma, Follicular, Grade 1	ATP6V1B2 MTHFR	1.23e-03	15	103	2	C1956130
Disease	Lymphoma, Large-Cell, Follicular	ATP6V1B2 MTHFR	1.23e-03	15	103	2	C0079745
Disease	Lymphoma, Small Cleaved-Cell, Follicular	ATP6V1B2 MTHFR	1.23e-03	15	103	2	C0079765
Disease	Lymphoma, Mixed-Cell, Follicular	ATP6V1B2 MTHFR	1.23e-03	15	103	2	C0079758
Disease	myocardial infarction	CTTNBP2 FN1 DYNC2H1 AS3MT REST AP3D1	1.45e-03	350	103	6	EFO_0000612
Disease	Fetal Alcohol Syndrome	CHL1 REST	1.59e-03	17	103	2	C0015923
Disease	Mammary Neoplasms, Experimental	KRT5 FN1 RASGRF2 LNPEP	2.16e-03	155	103	4	C0024668
Disease	selenium measurement, response to dietary selenium supplementation	TRIO LRRC8B	2.20e-03	20	103	2	EFO_0006331, EFO_0600021
Disease	serum homoarginine measurement	AGXT2 KCNQ1	2.20e-03	20	103	2	EFO_0005421
Disease	Lymphoma, Follicular	ATP6V1B2 MTHFR	2.20e-03	20	103	2	C0024301
Disease	Neutropenia	MTHFR AP3D1	2.43e-03	21	103	2	C0027947
Disease	Mammary Carcinoma, Human	KRT5 FN1 DYNC2H1 GPX4 MTHFR ITSN2 FGFR1	2.47e-03	525	103	7	C4704874
Disease	Mammary Neoplasms, Human	KRT5 FN1 DYNC2H1 GPX4 MTHFR ITSN2 FGFR1	2.47e-03	525	103	7	C1257931
Disease	Mammary Neoplasms	KRT5 FN1 DYNC2H1 GPX4 MTHFR ITSN2 FGFR1	2.53e-03	527	103	7	C1458155
Disease	Carcinomatosis	KRT5 FN1 RASGRF2 TP63	2.60e-03	163	103	4	C0205699
Disease	Carcinoma, Spindle-Cell	KRT5 FN1 RASGRF2 TP63	2.60e-03	163	103	4	C0205697
Disease	Undifferentiated carcinoma	KRT5 FN1 RASGRF2 TP63	2.60e-03	163	103	4	C0205698
Disease	Anaplastic carcinoma	KRT5 FN1 RASGRF2 TP63	2.60e-03	163	103	4	C0205696
Disease	Manic	STAB1 MTHFR DNAH8	2.60e-03	78	103	3	C0338831
Disease	electrocardiography	PACSIN1 OBSCN ARMC9 RADIL USP40 KCNQ1 FGFR1	2.61e-03	530	103	7	EFO_0004327
Disease	Carcinoma	KRT5 FN1 RASGRF2 TP63	2.65e-03	164	103	4	C0007097
Disease	transitional cell carcinoma (is_implicated_in)	MTHFR TP63	2.66e-03	22	103	2	DOID:2671 (is_implicated_in)
Disease	QT interval	CHL1 RASGRF2 PTPRG USP40 KCNQ1 IL5RA BRWD1	2.72e-03	534	103	7	EFO_0004682
Disease	Breast Carcinoma	KRT5 FN1 DYNC2H1 GPX4 MTHFR ITSN2 FGFR1	2.83e-03	538	103	7	C0678222
Disease	Cleft Palate	NEDD4L TP63 FGFR1	2.89e-03	81	103	3	C0008925
Disease	Hodgkins lymphoma	TEX55 STAB1 PTPRK	3.00e-03	82	103	3	EFO_0000183
Disease	mean platelet volume	PCDHGB2 PCDHGA10 PCDHGA5 PCDHGA1 CAPZA1 REST AZIN1 MTHFR KCNQ1 AFF1	3.02e-03	1020	103	10	EFO_0004584
Disease	systemic mastocytosis	TPSD1 NAV3	3.44e-03	25	103	2	MONDO_0016586
Disease	triacylglycerol 52:6 measurement	CAMK2A MAU2	3.44e-03	25	103	2	EFO_0010418

Protein segments in the cluster

Peptide	Gene	Start	Entry
GRQNERVVIQYHYTQ	PTPRG	1011	P23470
ERYQSLGYNRVLEIH	AGXT2	56	Q9BYV1
ESKNQVHRRGEYNVY	PPP2R2B	56	Q00005
RQQLAYGIYVIHQAG	B4GALT3	151	O60512
DYLLQYRAIHSAEQQ	ELL3	286	Q9HB65
DYAVQQYVRDSRVHQ	ACAD8	381	Q9UKU7
RSYVFYRHQQEQEAE	BAK1	36	Q16611
QQLDYGIYVIHQAEG	B4GALT4	151	O60513
LGNVIDNYVYEHTLT	AZIN1	21	O14977
VLKIQVHYYEDGNVQ	CAPZA1	191	P52907
RAYIAYELNSVQHRQ	ACACA	1156	Q13085
LQIQRNDYVHALVTY	PRMT8	296	Q9NR22
VLLVVHNESQNLYGY	CEACAM7	51	Q14002
EYQNQEIHNLGRFIT	BMS1	226	Q14692
GHIQAVYVQNVVKLY	AP3D1	516	O14617
ARQIYIYNEKIVNGH	NUP93	186	Q8N1F7
QGYIHELIQTEERYM	ITSN2	1211	Q9NZM3
QFTLQHVPDYRQNVY	PCDHGA5	881	Q9Y5G8
LVQDQYGNYVIQHVL	PUM2	916	Q8TB72
YKVIQTYLEQTGSNH	PARP3	336	Q9Y6F1
TKRVHNNIVYNEYIS	KIN	86	O60870
GYSQQHDSLVYVLNR	RADIL	256	Q96JH8
INEAYGYQIQHIQGL	NR1I3	326	Q14994
LSIRGEYQINFHIVN	MUC16	14196	Q8WXI7
RHLVNVYYLEEAAQG	REST	1081	Q13127
RTIIQYIHDNYFLVN	MTHFR	606	P42898
YDVRDVIEQYSQGHL	KCNQ1	536	P51787
LTQHFVQENYLEYRQ	MAGEA3	246	P43357
VYVQLYLQHLTARNR	TMPO	36	P42166
YHIYENGTLQINRTT	CHL1	471	O00533
QNQDRKHRTYVYVLT	NUDT4B	86	A0A024RBG1
YNKIQADYHNLIGVT	ARMC9	231	Q7Z3E5
YQTKYEELQQTAGRH	KRT5	361	P13647
YVRTGTYQRAILQNH	CARM1	166	Q86X55
QFTLQHVPDYRQNVY	PCDHGA10	886	Q9Y5H3
QFTLQHVPDYRQNVY	PCDHGB2	881	Q9Y5G2
QYYQSLVELQQRVTH	NAV3	191	Q8IVL0
INHTIERILQYYVAE	DNAH8	476	Q96JB1
QVYANGIRNIDLHYI	MARCHF6	791	O60337
QAEILEYAYHGQIAI	LNPEP	231	Q9UIQ6
HNLVIQYAGQGRYEV	KLC3	211	Q6P597
VYVQLYLQHLTARNR	TMPO	36	P42167
AQKYVERIHYIGQNE	HMOX2	131	P30519
QKIHQTYRVQYIQDI	PPP4R3B	261	Q5MIZ7
QRDQYLGHLQQYVAA	GOLGA2	611	Q08379
LGHLQQYVAAYQQLT	GOLGA2	616	Q08379
RSYREHIEQQIQTYQ	EXOC7	606	Q9UPT5
LRIQNDLHRQQYSYI	LRRC8B	91	Q6P9F7
LHNLVIQYASQGRYE	KLC2	201	Q9H0B6
LQKQHLEAVGAYQYV	MOGAT3	16	Q86VF5
LVQDQYGNYVIQHVL	PUM1	1036	Q14671
LNLAENSSYIHVYRE	PACSIN1	256	Q9BY11
NSSYIHVYRELEQAI	PACSIN1	261	Q9BY11
EYQVVIGNDTTHYII	PRTG	466	Q2VWP7
QHYLEQPVERVQRYQ	OBSCN	5826	Q5VST9
YLPQHTIETYRQQQQ	TP63	426	Q9H3D4
TRVGLSYIYNTVQQH	COG6	546	Q9Y2V7
NYFTYRIQQNLHIVL	DYNC2H1	2766	Q8NCM8
DYEVKIHNTRNGYLQ	IL5RA	271	Q01344
LNHQYEGVTETVYNL	CD1C	166	P29017
GEYQHVQQEYGVHLR	CGNL1	6	Q0VF96
QNYLRLVEQYHNVIF	CTTNBP2	1111	Q8WZ74
IVENEYGSINHTYQL	FGFR1	231	P11362
YGSINHTYQLDVVER	FGFR1	236	P11362
VYEGQLISIQQYGHQ	FN1	676	P02751
QERLVYRTHIYIQTD	COG3	461	Q96JB2
NHILYLIENYQTVVI	DHX35	61	Q9H5Z1
VLQYLYQEGILTENH	CRADD	26	P78560
ALQNVHEEVALRYYG	AS3MT	46	Q9HBK9
GHEAYIEAVRRNNIY	BRWD1	971	Q9NSI6
VRHLIQQEIYSINYE	ATF7IP2	321	Q5U623
QIRDHINGRVLYYAT	LAMB3	1156	Q13751
TEVNYTQLVDLHARY	GPX4	76	P36969
YIREGNRHQEVLYSL	MAU2	426	Q9Y6X3
YTKQILQGVAYLHEN	MAP3K19	1166	Q56UN5
LHNLVIQYASQGRYE	KLC1	216	Q07866
LLSYEEYGHLQINAV	PHKB	161	Q93100
YGNIIAYDHSRVILQ	PTPRK	916	Q15262
QFTLQHVPDYRQNVY	PCDHGA1	881	Q9Y5H4
RQHQAQIDQYVGLVT	RTN2	496	O75298
YITEGQIYVDRQLHN	ATP6V1B2	371	P21281
AALRVQLREQHLYYQ	TPSD1	91	Q9BZJ3
EIDQGKGYHIRNQTY	TEX55	471	Q96M34
RVYSIHQGDYIQLGV	RNF8	96	O76064
RSRELQYVYVDNNIH	LRRC28	201	Q86X40
YQEFVRNHQYSLQVL	RASGRF2	336	O14827
YVYINEATRHVLQSR	EPPK1	1766	P58107
QILEGVYYLHQNNIV	STK17B	141	O94768
NYIIAIREHVYNGQV	SETMAR	191	Q53H47
LNRHTLTYEDNGYVV	MPTX1	116	A8MV57
EDQHRLYQQIKAGAY	CAMK2A	216	Q9UQM7
GNYVRNIRHYEITKQ	SOS1	146	Q07889
EAVLVRRQDHTYYQG	RIOX1	226	Q9H6W3
DLVHYTRQGFQQLQE	AFF1	1191	P51825
QAVILYHLRQYTEAI	CNOT10	116	Q9H9A5
QQALYELSYHVIKGN	THOC2	46	Q8NI27
NLVSYQVHKRGVVEY	POLR3C	61	Q9BUI4
HLQLERINVYYNEAS	TUBB8	41	Q3ZCM7
YIRSLNQFQIAVQHY	RMC1	486	Q96DM3
RDLYATINHNVYEVR	SAGE2P	206	A6NJ88
QELVRYHIYNHGQLT	STAB1	571	Q9NY15
YSQIHYAQDLDDVIR	ZCCHC7	36	Q8N3Z6
DVILENYHNLISVGY	ZNF26	41	P17031
VHKEGYNELNQYLTT	ZNF493	6	Q6ZR52
NLYRDVMVENYNHLV	ZNF614	31	Q8N883
QRYIRELQYNHTGTQ	VASH1	126	Q7L8A9
DLIYRLYHGTIVNQI	USP40	156	Q9NVE5
VYHGEYIDQAQNRIQ	MST1R	1096	Q04912
VQLNTTYYIHQLLGN	TRIO	2941	O75962
DLRNYQYTLHNIDQL	ZFYVE16	1231	Q7Z3T8
QKVTLRRYENYGHDN	ZNF737	96	O75373
QTLVTDIDYRNYLHE	NEB	3831	P20929
EKVDNLGRTYYVNHN	NEDD4L	201	Q96PU5